Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

DSpace Repository

Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation

Author: Forschner, Julia; Huynh, Julia; Schroeder, Christopher; Armeanu-Ebinger, Sorin; Seibel-Kelemen, Olga; Gschwind, Axel; Bonzheim, Irina; Eigentler, Thomas K.; Amaral, Teresa; Ossowski, Stephan; Flatz, Lukas; Garbe, Claus; Forschner, Andrea; Reitmajer, Markus
Tübinger Autor(en):
Forschner, Julia
Schroeder, Christopher
Armeanu-Ebinger, Sorin
Seibel-Kelemen, Olga
Gschwind, Axel
Bonzheim, Irina
Amaral, Teresa
Ossowski, Stephan
Flatz, Lukas
Garbe, Claus
Reitmajer, Markus
Forschner, Andrea Lydia
Published in: Frontiers in Oncology (2025), Bd. 15, Article 1618596
Verlagsangabe: Lausanne : Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fonc.2025.1618596
ISSN: 2234-943X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)